Transplant nephrologist and epidemiologist at the University of Pennsylvania.
Apr 17, 2023 • 10 tweets • 2 min read
The United Network for Organ Sharing passed a policy requiring centers to estimate kidney function without race. I support that. However, by applying the rule retroactively to all waitlisted Black patients, UNOS ignited equity concerns. And now, a lawsuit: tinyurl.com/4uhxnb5e
My central contention: this policy is undermining trust in the allocation system. For some, the policy is not aggressive enough in repairing injustice. The lawsuit claims that race-based eGFR was inaccurate, invalid + that Black patients are due faster + bigger remedies
Jul 30, 2020 • 8 tweets • 2 min read
I also recognize the value of Dr. Powe’s thoughtful piece. I liked his call for the patient voice. I share concerns about unintended consequences of eliminating race-based eGFR equations. Yet, I explain the state of the art differently. @AmakaEMD@DorothyERoberts@Neil_R_Powe
A) Race is a social construct. Promoting the bogus biological concept of race is conceptually imprecise and can be harmful.
B) We require good ethics and good science to advance the field of kidney function estimation.
